ReviewHematology/oncology clinics of North America2014

Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches.

Paul J Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.